Table 1.
Absolute frequency of B and T lymphocytes and clinical information of the twins.
| Twin 1 | Twin 2 | |||||||
|---|---|---|---|---|---|---|---|---|
| DPI | 0 | 15 | 30 | 120 | 0 | 15 | 30 | 120 |
| %CD19+ | 15.16 | 14.27 | 13.17 | 13.30 | 11.90 | 13.46 | 13.39 | 12.01 |
| %CD3+ | 62.40 | 65.50 | 62.10 | 62.10 | 60.10 | 62.50 | 65.70 | 60.90 |
| %CD4+ | 42.10 | 48.90 | 44.70 | 36.80 | 34.00 | 39.30 | 47.00 | 38.50 |
| %CD8+ | 21.20 | 21.60 | 21.40 | 20.80 | 12.70 | 15.50 | 16.80 | 10.80 |
| CD4/CD8 | 2.00 | 2.30 | 2.10 | 1.80 | 2.70 | 2.50 | 2.80 | 3.60 |
| HLA-AI type | A*24:02 | A*24:02 | ||||||
| HLA-AII type | A*68:02 | A*68:02 | ||||||
| BMI | 28.9 | 27.1 | ||||||
| AEPV | ||||||||
| 1st dose | yes | mild fever (37.7 °C), local pain, myalgia, headache | yes | local pain, myalgia, headache | ||||
| 2nd dose | no | no | ||||||
Legend: DPI: days post immunization; BMI: body mass index; AEPV: adverse events post immunization. *: it is a separator to define the international nomenclature of the HLA genotype.